DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Borgohain R, Szasz J, Stanzione P. et al.
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinsonʼs disease.
Mov Disord 2014;
29: 1273-80
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.